Atopic Dermatitis: Sailing beyond the Sunset with a Multitude of Novel Treatments

Atopic eczema or dermatitis (AD) is a chronic pruritic inflammatory cutaneous disorder with an incidence up to 20% in children and 10% in adults depending on region and ethnicity [...].

[1]  Terri A. Brown‐Whitehorn,et al.  Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From 2 Phase 3, Randomized, Double-blind Studies , 2022, Pediatrics.

[2]  C. Flohr,et al.  Requirements and expectations of high‐quality biomarkers for atopic dermatitis and psoriasis in 2021—a two‐round Delphi survey among international experts , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  M. Matijašić,et al.  Skin Microbiota in Atopic Dermatitis , 2022, International journal of molecular sciences.

[4]  P. Elias,et al.  Atopic Dermatitis: The Fate of the Fat , 2022, International journal of molecular sciences.

[5]  L. Beck,et al.  Skin barrier defects in atopic dermatitis: From old idea to new opportunity , 2021, Allergology international : official journal of the Japanese Society of Allergology.

[6]  M. Covington,et al.  Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream , 2021, Pharmaceutics.

[7]  M. Furue.  Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis , 2020, International journal of molecular sciences.

[8]  J. Szepietowski,et al.  Influence of Itch and Pain on Sleep Quality in Atopic Dermatitis and Psoriasis. , 2019, Acta dermato-venereologica.

[9]  J. Szepietowski,et al.  Quality of Life of Parents of Children with Atopic Dermatitis. , 2017, Acta dermato-venereologica.

[10]  L. Misery,et al.  The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries , 2014, The Journal of investigative dermatology.